UCI-led study finds that cancer immunotherapy may self-limit its efficacy

(University of California - Irvine) Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor of physiology& biophysics and member of the Institute for Immunology at the University of California, Irvine. Study results are published online in the journal Cell.
Source: EurekAlert! - Biology - Category: Biology Source Type: news